The Use of Nanomedicine to Target Signaling by the PAK Kinases for Disease Treatment
P21-activated kinases (PAKs) are serine/threonine kinases involved in the regulation of cell survival, proliferation, inhibition of apoptosis, and the regulation of cell morphology. Some members of the PAK family are highly expressed in several types of cancer, and they have also been implicated in...
Main Authors: | Yiling Wang, Audrey Minden |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/12/3565 |
Similar Items
-
Simultaneous Inhibition of BCR-ABL1 Tyrosine Kinase and PAK1/2 Serine/Threonine Kinase Exerts Synergistic Effect against Chronic Myeloid Leukemia Cells
by: Sylwia Flis, et al.
Published: (2019-10-01) -
The significance of PAK4 in signaling and clinicopathology: A review
by: Yu Xinbo, et al.
Published: (2022-06-01) -
2nd EURO-PAK International Conference on Sports Sciences & Physical Education
by: Saša Pišot
Published: (2020-10-01) -
Immunomodulating effect of nanoparticles used in nanomedicine
by: Gómez-Gallego, Diana Maryory, et al.
Published: (2016-10-01) -
The landscape of nanomedicines: An expert perspective
by: Nikolić Ines, et al.
Published: (2023-01-01)